Related Experiment Video
Updated: Feb 23, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Multiparticulate system combining taste masking and immediate release properties for the aversive compound
Magdalena Münster1, Corinna Schoch2, Carsten Schmidt2
1Merck KGaA, Pharmaceutical Technologies, Frankfurter Straße 250, 64293 Darmstadt, Germany; Institute of Pharmaceutics and Biopharmaceutics, Heinrich-Heine-University, Universitätsstr. 1, 40225 Düsseldorf, Germany.
Abstract:
The taste of pharmaceuticals is of particular importance as it highly affects the compliance of patients, especially for patient groups like children. In view of oral solid dosage forms, various taste masking techniques can be applied encapsulating the active pharmaceutical ingredient (API) to prevent the interaction with the taste buds. Despite a delayed drug release in saliva, an immediate drug release in gastrointestinal media is desirable for efficient drug absorption. This combinatory approach is of particular interest for poorly soluble drugs still demonstrating an aversive, bitter taste, e.g. praziquantel (PZQ). It is an anthelmintic drug of current importance for adults and children as it is the recommended therapy against schistosomiasis. First, a small scale screen was conducted to identify the most suitable polymer for a combinatorial approach of taste masking and immediate release for PZQ. Among various PZQ-polymer combinations Eudragit® E PO was chosen. Second, multiparticulate systems utilizing extrusion and spray-drying were generated comprising PZQ, Eudragit® E PO and a lipid as an additional taste masking agent. Spray-dried powders and ground extrudates showed as expected strong differences in terms of particle size distribution and morphological characteristics of the encapsulated PZQ. DSC and XRPD studies revealed the formation of an amorphous solid dispersion of PZQ after spray-drying in contrast to ground extrudates. This could be correlated to drug release studies. All formulations were subjected to non-sink dissolution studies in simulated salivary (SSF), gastric (spSGF) and intestinal (FaSSIF) media. Ground extrudates provided an efficient delayed release in SSF and immediate release and supersaturation in spSGF and FaSSIF for PZQ. Spray-dried powders revealed fast solubility kinetics and up to 5-fold supersaturation in biorelevant media, contrary to a taste masking effect. Moreover, XRPD-patterns of spray-dried powders after storage detected recrystallized PZQ resulting in varied dissolution profiles. Solid lipid extrusion combined with Eudragit® E PO enabled a promising taste masking of PZQ in SSF through encapsulation of the crystalline PZQ and further, a fast and reproducible dissolution in simulated gastric and intestinal media.
Related Concept Videos
Cholinergic Antagonists: Pharmacokinetics
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Oral Drug Delivery Systems: Delayed-Release Systems
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Modified-Release Drug Delivery Systems: Rate-Programmed II
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

